LINFOMAS Y TRASPLANTES
University of Melbourne
Melbourne, AustraliaPublicaciones en colaboración con investigadores/as de University of Melbourne (7)
2019
-
Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: Long-term results of the PRIMA study
Journal of Clinical Oncology, Vol. 37, Núm. 31, pp. 2815-2824
2017
-
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
Cancer Medicine, Vol. 6, Núm. 1, pp. 36-44
2016
-
Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first-line immunochemotherapy in the PRIMA trial
Journal of Clinical Oncology, Vol. 34, Núm. 22, pp. 2575-2582
2014
-
Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma
Blood
-
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: Pivotal study update demonstrates durable responses
Journal of Hematology and Oncology, Vol. 7, Núm. 1
2012
-
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Journal of Clinical Oncology, Vol. 30, Núm. 6, pp. 631-636